Further, metastatic pheochromocytoma and paraganglioma (PCPG), head and neck squamous cell carcinoma (HNSC), thyroid carcinoma (THCA), breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) tumors, exhibited higher expression levels of MXD3 than the corresponding primary tumors (Fig. 3C). The gene discussed is MXD3; the disease is endocervical adenocarcinoma.